Baseline and early 18F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy.

Details

Language :

English

ISSN :

17405025

Volume :

24

Issue :

1

Database :

Supplemental Index

Journal :

Cancer Imaging

Publication Type :

Academic Journal

Accession number :

178354106

Full Text :

https://doi.org/10.1186/s40644-024-00727-2